Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

(UPDATED) Meningitis Outbreak: Murder or Public Health Tragedy?

By Denise Lavoie, AP Legal Affairs Writer | March 16, 2017

Barry Cadden, center, arrives at the federal courthouse, Thursday, March 16, 2017, in Boston, before scheduled closing arguments in his trial. Cadden, a former pharmacy executive and the president of New England Compounding Center, is charged with causing the deaths in 2012 of 25 people who received tainted steroids manufactured by the pharmacy. (Credit: AP Photo/Steven Senne)

Was it murder or a tragic public health outbreak?

Prosecutors and defense attorneys in the trial of a former executive charged in a 2012 U.S. meningitis outbreak offered jurors opposing theories Thursday about a public health crisis that killed 64 people and injured about 700 others in 20 states.

Barry Cadden, the co-founder and former president of the New England Compounding Center, is charged in a massive racketeering indictment with second-degree murder in the deaths of 25 people, as well as fraud and other charges.

During closing arguments, Assistant U.S. Attorney Amanda Strachan told the jury that Cadden ran the company in an “extraordinarily dangerous” way, leading to contaminated steroids being shipped around the country, where doctors — trusting they were safe — injected them into patients who then became sick or died.

“It was preventable, but it happened because this man — Barry Cadden — decided to put profits before patients,” Strachan said.

She said Cadden cut corners and failed to follow industry regulations for cleanliness and sterility in the so-called “clean rooms” at NECC, where drugs were manufactured. She said NECC did not sterilize drugs long enough, didn’t test large enough samples and shipped out drugs before receiving the results of sterility tests.

“How could he know that these drugs were sterile and safe when he skipped all of these important steps? He couldn’t,” Strachan said. “He put patients’ lives at risk, and that is second-degree murder.”

She ended her closing argument by showing the jury photographs of each of the 25 people Cadden is charged with killing through what she called his “wanton and willful disregard” for human life.

Cadden’s lawyer, Bruce Singal, told jurors that Cadden is not responsible for the deaths.

“As horrible as each of these stories is, there is nothing that shows that Mr. Cadden did something that the government can link to the death of that person,” Singal said.

Singal said Glenn Chin, the supervisory pharmacist, was responsible for the day-to-day operations in the clean rooms and repeatedly allowed employees to cut corners, going against instructions from Cadden to “do it right.” Chinn, who faces similar charges, is expected to go on trial after Cadden. He has pleaded not guilty.

Singal reminded jurors about emails Cadden sent to an outside cleaning service reprimanding the company after he learned its employees had not followed proper procedures. Singal said prosecutors have “massively piled on” and appealed to the jurors’ emotions to try to convict Cadden of murder.

“This is indeed a tragic death case, but it is not a murder case, and there is a big, big difference between the two,” Singal said.

Singal played the jury a recording of a voicemail message Cadden left for a client after the outbreak was discovered, instructing the client to quarantine the steroids.

“We consider this an emergency,” Cadden said.

“As you go into the jury room, ask yourselves, ‘Are those the words of a murderer? Are those the actions of a murderer? And is that the voice of a man who murdered 25 people?'” Singal said.

Jurors were expected to begin deliberations late Thursday after receiving instructions on the law from the judge.

(Source: Associated Press)

Related Articles Read More >

This is the logo of Novartis.
Novartis opens new manufacturing plant in California
samsung biologics (1)
Samsung Biologics completes Bioepis spinoff to become pure-play pharma CDMO
Trelleborg grand opening of its Biopharma Center of Excellence in Northborough MA
Trelleborg opens expanded manufacturing facility in Massachusetts
This is the logo of Abbvie.
AbbVie invests $70M in U.S. biologics manufacturing, R&D expansion
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE